Alizyme plc

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

16 documents for Alizyme plc

- Reportlinker Adds World Anti-Obesity Drugs Market Report.
... worldwide such as Abbott Laboratories, Alizyme Plc, Amylin Pharmaceuticals, Inc., AstraZeneca Plc...
- Business Wire
- April 01, 2009
- Prohibited trade practices: Glaxo Wellcome plc et al.,
... to treat irritable bowel syndrome, to Alizyme plc; (7) assign all of Glaxo's relevant intellectu...
- FR, December 28, 2000
- Notices
- Federal Trade Commission
- Reportlinker Adds Pipeline and Commercial Insight: Obesity - the $11 Billion Market That Never Was.
...Forecasts to 2018 207 . Cetilistat, Alizyme Plc 210 . Drug profile 210 . Drug overview 210 . S...
- Business Wire
- July 28, 2009

- Healthshares(Tm) Announces Quarterly Rebalancing of Healthshares(Tm) Indexes
To: MEDICAL EDITORS Contact: Melissa Kanter of Edelman for XShares, +1-212-704-8261, melissa.kanter@edelman.com

...ALIZYME PLC AZM LN 27927589...
- U.S. Newswire
- September 17, 2007
- Research and Markets: Complete and Comprehensive Analysis of Protherics Plc which also Includes an Overview of the Industry they Operate in.
...- Protherics Plc . - Alizyme Plc . - Vernalis Plc . For more information visit ...
- Business Wire
- March 03, 2008
- Research and Markets: Global Strategic Business Report on Anti-Obesity Drugs with Most Recent Key Developments and Future Products in the Pipleline.
...* Abbott Laboratories (US) . * Alizyme Plc (UK) . * Amylin Pharmaceuticals, Inc. (US) . *...
- Business Wire
- April 07, 2009
- The Japanese Pharmaceutical Market Has Become Increasingly Difficult.
...- Abbott . - Affymax Inc . - Alizyme plc . - Andrx Corporation . - ASKA Pharmaceutical,...
- Business Wire
- May 12, 2008
- Research and Markets: Sales for the Pharmaceutical Company Takeda Increased by 7% to Reach 935,213 Million Yen.
...--Abbott . --Affymax Inc . --Alizyme plc . --Andrx Corporation . --ASKA Pharmaceutical,...
- Business Wire
- June 02, 2006
- CSR Outstanding Year Honoured by techMARK; Company Named techMARK Company of the Year.
... of the Year include, iSoft Group and Alizyme plc and this year, CSR defeated strong competition...
- Business Wire
- November 23, 2005
- Alizyme Honored Twice by Frost & Sullivan With Technology Innovation of the Year Awards for Prescription Drugs.
PALO ALTO, Calif. -- In a recent research study titled "U.S. Irritable Bowel Syndrome Therapeutics Markets," Frost & Sullivan recognized Alizyme with ...
- Business Wire
- January 10, 2005